Pharmaceutical Compositions Comprising Sorbitan Esters

Patent No. EP2685979 (titled "Pharmaceutical Compositions Comprising Sorbitan Esters") was filed by Alkermes Pharma Ireland on Mar 19, 2012. The application was issued on Aug 24, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKMay 24, 2017ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2685979

ALKERMES PHARMA IRELAND
Application Number
EP12712189A
Filing Date
Mar 19, 2012
Status
Opposition Rejected
Jan 25, 2022
Publication Date
Aug 24, 2016